Toxic Inhalational Injury-Associated Interstitial Lung Disease in Children

被引:38
作者
Lee, Eun [1 ,2 ,3 ]
Seo, Ju-Hee [4 ]
Kim, Hyung Young [5 ]
Yu, Jinho [1 ,2 ]
Jhang, Won-Kyoung [1 ]
Park, Seong-Jong [1 ]
Kwon, Ji-Won [6 ]
Kim, Byoung-Ju [7 ]
Do, Kyung-Hyun [8 ]
Cho, Young Ah [8 ]
Kim, Sun-A [9 ]
Jang, Se Jin [9 ]
Hong, Soo-Jong [1 ,2 ,3 ]
机构
[1] Univ Ulsan, Coll Med, Dept Pediat, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Childhood Asthma Atopy Ctr, Seoul 138736, South Korea
[3] Univ Ulsan, Coll Med, Res Ctr Standardizat Allerg Dis, Asan Med Ctr,Childrens Hosp, Seoul 138736, South Korea
[4] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea
[5] Kosin Univ, Coll Med, Dept Pediat, Pusan, South Korea
[6] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam, South Korea
[7] Inje Univ, Haeundae Paik Hosp, Dept Pediat, Buasn, South Korea
[8] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul 138736, South Korea
[9] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul 138736, South Korea
关键词
Lung Disease; Interstitial; Pulmonary Fibrosis; Bronchioles; Inhalation; Toxin; Biological; HYPERSENSITIVITY PNEUMONITIS; DIAGNOSIS; THERAPY;
D O I
10.3346/jkms.2013.28.6.915
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interstitial lung disease in children (chILD) is a group of disorders characterized by lung inflammation and interstitial fibrosis. In the past recent years, we noted an outbreak of child in Korea, which is possibly associated with inhalation toxicity. Here, we report a series of cases involving toxic inhalational injury-associated chILD with bronchiolitis obliterans pattern in Korean children. This study included 16 pediatric patients confirmed by lung biopsy and chest computed tomography, between February 2006 and May 2011 at Asan Medical Center Children's Hospital. The most common presenting symptoms were cough and dyspnea. The median age at presentation was 26 months (range: 12-47 months), with high mortality (44%). Histopathological analysis showed bronchiolar destruction and centrilobular distribution of alveolar destruction by inflammatory and fibroproliferative process with subpleural sparing. Chest computed tomography showed ground-glass opacities and consolidation in the early phase and diffuse centrilobular nodular opacity in the late phase. Air leak with severe respiratory difficulty was associated with poor prognosis. Although respiratory chemicals such as humidifier disinfectants were strongly considered as a cause of this disease, further studies are needed to understand the etiology and pathophysiology of the disease to improve the prognosis and allow early diagnosis and treatment.
引用
收藏
页码:915 / 923
页数:9
相关论文
共 50 条
  • [41] Pathological features of connective tissue disease-associated interstitial lung disease in transbronchial cryobiopsies
    Churg, Andrew
    Poletti, Venerino
    Ravaglia, Claudia
    Matej, Radoslav
    Vasakova, Martina Koziar
    Hornychova, Helena
    Stewart, Brian
    Patel, Divya
    Duarte, Ernesto
    Gomez Manjarres, Diana C.
    Mehta, Hiren J.
    Vaszar, Laszlo T.
    Tazelaar, Henry
    Wright, Joanne L.
    HISTOPATHOLOGY, 2025, 86 (02) : 260 - 267
  • [42] Idiopathic or connective tissue disease-associated interstitial lung disease: a case of HRCT mimicry
    Flaherty, Kevin R.
    Khanna, Dinesh
    THORAX, 2014, 69 (03) : 205 - 206
  • [43] Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
    Romagnoli, M.
    Nannini, C.
    Piciucchi, S.
    Girelli, F.
    Gurioli, C.
    Casoni, G.
    Ravaglia, C.
    Tomassetti, S.
    Gurioli, Ch.
    Gavelli, G.
    Carloni, A.
    Dubini, A.
    Cantini, F.
    Chilosi, M.
    Poletti, V.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (02) : 384 - 391
  • [44] Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
    Kim, E. J.
    Elicker, B. M.
    Maldonado, F.
    Webb, W. R.
    Ryu, J. H.
    Van Uden, J. H.
    Lee, J. S.
    King, T. E., Jr.
    Collard, H. R.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (06) : 1322 - 1328
  • [45] Management of connective tissue disease-associated interstitial lung disease
    Talari, Keerthi
    INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (05) : 87 - 91
  • [46] Rituximab in connective tissue disease-associated interstitial lung disease
    Duarte, Ana Catarina
    Cordeiro, Ana
    Fernandes, Bruno Miguel
    Bernardes, Miguel
    Martins, Patricia
    Cordeiro, Ines
    Santiago, Tania
    Seixas, Maria Ines
    Ribeiro, Ana Roxo
    Santos, Maria Jose
    CLINICAL RHEUMATOLOGY, 2019, 38 (07) : 2001 - 2009
  • [47] Cyclophosphamide for connective tissue disease-associated interstitial lung disease
    Barnes, Hayley
    Holland, Anne E.
    Westall, Glen P.
    Goh, Nicole S. L.
    Glaspole, Ian N.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [48] Biological treatments and connective tissue disease associated interstitial lung disease
    Panopoulos, Stylianos T.
    Sfikakis, Petros P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (05) : 362 - 367
  • [49] Management of Connective Tissue Disease-Associated Interstitial Lung Disease
    Kawano-Dourado, Leticia
    Lee, Joyce S.
    CLINICS IN CHEST MEDICINE, 2021, 42 (02) : 295 - 310
  • [50] Connective tissue disease-associated interstitial lung disease: a review
    Gutsche, Markus
    Rosen, Glenn D.
    Swigris, Jeffrey J.
    CURRENT PULMONOLOGY REPORTS, 2012, 1 (04) : 224 - 232